Distribution of company announcements to the professional platforms, finance portals and syndication of important corporate news to a wide variety of news aggregators and financial news systems.
Küsnacht/Zürich, Switzerland, Dec 7, 2007 - (Hugin via ABN Newswire) - Daniel Koller will be new CFO of Bellevue Group
Daniel Hefti, CFO of the Group since May 2000, will leave the company after year-end closing and take up a new challenge. The Board of Directors of Bellevue Group has appointed Daniel Koller at that time as the new Chief Financial Officer of Bellevue Group. Daniel Koller is Swiss Certified Accountant. Since 2004 he worked for Valartis Group as Controller and, since May 2007, as Group Compliance Officer. He worked for Ernst & Young from 1995 to 2004 in the Audit department.
Other personnel changes
Hans-Jörg Graf will not stand for reelection to the Board of Directors of Bellevue Group at the next Annual General Meeting on April 4, 2008. A direct replacement is not planned since the Board of Directors was enlarged after the election of three new members at this year's general meeting. Hans-Peter Diener will assume the position of CEO of Bellevue Asset Management effective January 1, 2008. He has been with Bellevue Group since November 1, 2007. Hans-Peter Diener was previously CEO of Walter Meier (formerly WMH Walter Meier Holding AG) and has extensive management experience. Roland Maier, current CEO of Bellevue Asset Management, will then be able to focus primarily on the investment management of BB BIOTECH, the flagship of the Bellevue Group. Gregor Greber, Head of Corporate Finance, is leaving Bellevue Group at the end of the current year by own request. His successor will be determined in the coming weeks.
A word of thanks
The Board of Directors and the Group Executive Board, also on behalf of the shareholders, would like to express their gratitude, to Hans-Jörg Graf, a partner and co-founder of Bellevue Group, and to Daniel Hefti for their valuable services and unwavering dedication to the company during the past 14 and 8 years, respectively. Thanks is also extended to Gregor Greber for the work rendered in Corporate Finance.
For further information: Bellevue Group AG, Seestrasse 16, 8700 Küsnacht Anja Stubenrauch, Tel. +41 (44) 267 67 06, as@bellevue.ch
Bellevue Group is an independent financial group listed on the SWX Swiss Exchange that specializes in Investment Banking and Asset Management. In particular, its business operations include Asset Management and Investment Advisory services for institutional clients, Brokerage and Research on Swiss Stocks as well as Corporate Finance activities. Bellevue Asset Management, the world's largest financial investor in biotechnology and medical technology, employs an interdisciplinary team of financial analysts. This team includes biochemists, physicians and economists and primarily covers Swiss stocks and global medtech companies. The investment companies BB BIOTECH and BB MEDTECH are managed by this team of professionals. The Bank am Bellevue is a leading broker focused on the Swiss market.
--- End of Message ---
Bellevue Group AG Seestrasse 16, Postfach Küsnacht/Zürich Switzerland
